Heart Rate Variability in Extracorporeal Membrane Oxygenation (ECMO) Patients
Clinical Application of Multimodal Physiological Signal Analysis in Critical Ill Patients Depending on Extracorporeal Membrane Oxygenation
1 other identifier
observational
40
1 country
1
Brief Summary
National Taiwan University Hospital is the leading center for care of patients with extracorporeal membrane oxygenation (ECMO). The predictable factors associated with outcomes are still lacking in patients with the ECMO support. The aim of this study is to collect the electrical signals stored in the monitor of intensive care units (ICUs), which are analyzed by the bio-informatics software. The pre-, peri-, and post-ECMO heart rate variability, including linear and non-linear analysis is calculated to address the association with outcomes of patients with ECMO. In addition, we collected the demographics, body temperature, respiratory rate, and blood pressure to investigate the causes of heart rate variability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2010
CompletedFirst Posted
Study publicly available on registry
November 24, 2010
CompletedStudy Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedApril 22, 2011
March 1, 2011
5 months
November 22, 2010
April 21, 2011
Conditions
Keywords
Eligibility Criteria
Patients with the support of extracorporeal membrane oxygenation
You may qualify if:
- Adults patients (aged \> 18 years; less than 90 years old) used ECMO for cardiopulmonary support
You may not qualify if:
- Patients used illicit drugs
- Patients received heart transplantation
- Patients have the history of arrhythmia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
Study Officials
- STUDY CHAIR
Wen-Je Ko, M.D., Ph.D.
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 22, 2010
First Posted
November 24, 2010
Study Start
July 1, 2011
Primary Completion
December 1, 2011
Study Completion
December 1, 2012
Last Updated
April 22, 2011
Record last verified: 2011-03